Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) had its price objective decreased by equities research analysts at Alliance Global Partners from $18.00 to $8.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The firm presently has a 'buy' rating on the stock. Separately, StockNews.com raised shares of Tonix Pharmaceuticals to […] The post Tonix Pharmaceuticals (NASDAQ:TNXP) PT Lowered to $8.00 first appeared on Daily Political .

https://www.dailypolitical.com/2023/08/01/tonix-pharmaceuticals-nasdaqtnxp-pt-lowered-to-8-00.html

#dailypolitical